Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cabaletta Bio and other ETFs, options, and stocks.
Cabaletta Bio, Inc. operates as a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor to selectively bind and eliminate B cells that produce disease-causing autoantibodies.
52 Week high
52 Week low
— per share
Expected Mar 15, Pre-Market